InvestorsHub Logo

learningcurve2020

11/14/20 3:32 PM

#330300 RE: JRIII #330286

That might explain why the usual pumpers here never acknowledge the endpoint changes are material...Because then they’d have to acknowledge the company is not in compliance.

So I guess you’re saying, JR, that Powers just went ahead with the trial anyway, without the FDA or other regulators approval. But do you think they at least gave her a nod?

Sammy 967

11/14/20 4:47 PM

#330316 RE: JRIII #330286

So why do you still own the shares of company that failed?

drugrunner

11/14/20 5:59 PM

#330346 RE: JRIII #330286

What is INTERESTING

we have the unholy trinity
EX-LC—JR
trying to convince us of what is relevant and when

It’s my opinion that the PFS was muddied by pseudo progression.

Tumors grew, or so they thought

But those patients still were living much longer

U can argue the merits of what should have been reported and when

But the only real debate is survival

When u three intelligencia
can explain away overall survival
of up to 15-20% ++ then I will attempt to answer your adventures of trivial pursuit

FREE DRUGGIE from the shackles of one post per day

biosectinvestor

11/14/20 6:31 PM

#330358 RE: JRIII #330286

Your point is clearly refuted by the 2017 Federal Court decision dismissing the same claim. Are you asserting that a Federal judge LIED in his opinion?

These assertions are litigated on bulletin boards because shorts were shut down completely in the courts. There are no rules of evidence here so you can say whatever BS you’d like.

Court decision:
https://drive.google.com/file/d/0B9XkDkpumQZSNklfRHVoUU10OVk/view?usp=drivesdk